<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Atherosclerosis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:16 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1013005">
<meta name="Category" content="Concern">
<meta name="Article" content="Atherosclerosis">
<title>Aterosclerosis-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Aterosclerosis</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Atherosclerosis.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Nelson GJ. Dietary fat, <em>trans</em> fatty acids, and risk of coronary heart
disease. <em>Nutr Rev</em> 1998;250&#8211;2.</li>

<li class="Ref">Ascherio A, Willett WC. Health effects of trans fatty acids. <em>Am J Clin
Nutr</em> 1997;66(suppl):1006S&#8211;10S [review].</li>

<li class="Ref">Li D, Sinclair A, Wilson A, et al. Effect of dietary alpha-linolenic acid on
thrombotic risk factors in vegetarian men. <em>Am J Clin Nutr</em> 1999;69:872&#8211;82.</li>

<li class="Ref">Cunnane SC, Hamadeh MJ, Liede AC, et al. Nutritional attributes of traditional
flaxseed in healthy young adults. <em>Am J Clin Nutr</em> 1994;61:62&#8211;8.</li>

<li class="Ref">De Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic-rich
diet in secondary prevention of coronary heart disease. <em>Lancet</em>
1994;343:1454&#8211;9.</li>

<li class="Ref">De Lorgeril M, Salen P, Martin J-L, et al. Mediterranean diet, traditional
risk factors, and the rate of cardiovascular complications after myocardial infarction. Final
report of the Lyon Diet Heart Study. <em>Circulation</em> 1999;99:779&#8211;85.</li>

<li class="Ref">Rice RD. Mediterranean diet. <em>Lancet</em> 1994;344:893&#8211;4
[letter].</li>

<li class="Ref">Anderson JW, Hanna TJ, Peng X, Kryscio RJ. Whole grain foods and heart disease
risk. <em>J Am Coll Nutr</em> 2000;19(3 Suppl):291S&#8211;299S.</li>

<li class="Ref">Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of
dietary fiber: a meta-analysis. <em>Am J Clin Nutr</em> 1999;69:30&#8211;42.</li>

<li class="Ref">Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of
dietary fiber: a meta-analysis. <em>Am J Clin Nutr</em> 1999;69:30&#8211;42.</li>

<li class="Ref">Jenkins DJA, Kendall CWC, Ransom TPP. Dietary fiber, the evolution of the
human diet and coronary heart disease. <em>Nutr Res</em> 1998;18:633&#8211;52 [review].</li>

<li class="Ref">Wolk A, Manson JE, Stampfer MJ, et al. Long-term intake of dietary fiber and
decreased risk of coronary hart disease among women. <em>JAMA</em>
1999;281:1998&#8211;2004.</li>

<li class="Ref">Knopp RH, Superko HR, Davidson M, et al. Long-term blood cholesterol-lowering
effects of a dietary fiber supplement. <em>Am J Prev Med</em> 1999;17:18&#8211;23.</li>

<li class="Ref">Raloff J. Oxidized lipids: a key to heart disease? <em>Sci News</em>
1985;127:278.</li>

<li class="Ref">Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse
coronary heart disease? <em>Lancet</em> 1990;336:129&#8211;33.</li>

<li class="Ref">He J, Ogden LG, Vupputuri S, et al. Dietary sodium intake and subsequent risk
of cardiovascular disease in overweight adults. <em>JAMA</em> 1999;282:2027&#8211;34.</li>

<li class="Ref">Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic
load, carbohydrate intake, and risk of coronary heart disease in US women. <em>Am J Clin
Nutr</em> 2000;71:1455&#8211;61.</li>

<li class="Ref">Michael Pittilo R. Cigarette smoking, endothelial injury and cardiovascular
disease. <em>Int J Exp Pathol</em> 2000;81:219&#8211;30 [review].</li>

<li class="Ref">Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality
after myocardial infarction: meta-analysis of cohort studies. <em>Arch Intern Med</em>
2000;160:939&#8211;44 [review].</li>

<li class="Ref">Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute
myocardial infarction. <em>Am Heart J</em> 1991;122:438.</li>

<li class="Ref">Abate N. Obesity and cardiovascular disease. Pathogenetic role of the
metabolic syndrome and therapeutic implications. <em>J Diabetes Complications</em>
2000;14:154&#8211;74 [review].</li>

<li class="Ref">Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the
pathogenesis of cardiovascular disease and implications for therapy. <em>Circulation</em>
1999;99:2192&#8211;217 [review].</li>

<li class="Ref">Gabriel HH, Heine G, Kroger K, et al. Exercise and atherogenesis: where is the
missing link? <em>Exerc Immunol Rev</em> 1999;5:96&#8211;102 [review].</li>

<li class="Ref">Sebregts EH, Falger PR, Bar FW. Risk factor modification through
nonpharmacological interventions in patients with coronary heart disease. <em>J Psychosom
Res</em> 2000;48:425&#8211;41 [review].</li>

<li class="Ref">Miller TQ, Smith TW, Turner CW, et al. A meta-analytic review of research on
hostility and physical health. <em>Psychol Bull</em> 1996;119:322&#8211;48.</li>

<li class="Ref">Kawachi I, Sparrow D, Spiro A 3rd, et al. A prospective study of anger and
coronary heart disease. The Normative Aging Study. <em>Circulation</em>
1996;94:2090&#8211;5.</li>

<li class="Ref">Thomas SA, Friedmann E, Wimbush F, Schron E. Psychological factors and
survival in the cardiac arrhythmia suppression trial (CAST): a reexamination. <em>Am J Crit
Care</em> 1997;6:116&#8211;26.</li>

<li class="Ref">Angerer P, Siebert U, Kothny W, et al. Impact of social support, cynical
hostility and anger expression on progression of coronary atherosclerosis. <em>J Am Coll
Cardiol</em> 2000;36:1781&#8211;8.</li>

<li class="Ref">Suarna C, Hood RL, Dean RT, Stocker R. Comparative antioxidant activity of
tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat
and human lipoproteins. <em>Biochim Biophys Acta</em> 1993;1166:163&#8211;70.</li>

<li class="Ref">Tomeo AC, Geller M, Watkins TR, et al. Antioxidant effects of tocotrienols in
patients with hyperlipidemia and carotid stenosis. <em>Lipids</em> 1995;30:1179&#8211;83.</li>

<li class="Ref">Ando M, Sanaka T, Nihei H. Eicosapentanoic acid reduces plasma levels of
remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. <em>J Am
Soc Nephrol</em> 1999;10:2177&#8211;84.</li>

<li class="Ref">Olszewski AJ, McCully KS. Fish oil decreases serum homocysteine in
hyperlipemic men. <em>Coron Artery Dis</em> 1993;4:53&#8211;60.</li>

<li class="Ref">Phillipson BE, Rothrock DW, Connor WE, et al. Reduction of plasma lipids,
lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. <em>
N Engl J Med</em> 1985;312:1210&#8211;6.</li>

<li class="Ref">Haglund O, Wallin R, Luostarinen R, Saldeen T. Effects of a new fluid fish oil
concentrate, ESKIMO-3, on triglycerides, cholesterol, fibrinogen and blood pressure. <em>J
Intern Med</em> 1990;227:347&#8211;53.</li>

<li class="Ref">Haglund O, Luostarinen R, Wallin W, Saldeen T. Effects of fish oil on
triglycerides, lipoprotein(a), atherogenic index and fibrinogen. Influence of the degree of
purification of the oil. <em>Nutr Res</em> 1992;12:455&#8211;68.</li>

<li class="Ref">Haglund O, Luostarinen R, Wallin R, et al. The effects of fish oil on
triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin
E. <em>J Nutr</em> 1991;121:165&#8211;9.</li>

<li class="Ref">Leng GC, Lee AJ, Fowkes FG, et al. Randomized controlled trial of
gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. <em>Clin
Nutr</em> 1998;17:265&#8211;71.</li>

<li class="Ref">Leaf A, Jorgensen MB, Jacobs AK, et al. Do fish oils prevent restenosis after
coronary angioplasty? <em>Circulation</em> 1994;90:2248&#8211;57.</li>

<li class="Ref">Sacks FM, Stone PH, Gibson CM, et al. Controlled trial of fish oil for
regression of human coronary atherosclerosis. HARP Research Group. <em>J Am Coll Cardiol</em>
1995;25:1492&#8211;8.</li>

<li class="Ref">von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty
acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. <em>
Ann Intern Med</em> 1999;130:554&#8211;62.</li>

<li class="Ref">Sacks FM, Stone PH, Gibson CM, et al. Controlled trial of fish oil for
regression of human coronary atherosclerosis. HARP Research Group. <em>J Am Coll Cardiol</em>
1995;25:1492&#8211;8.</li>

<li class="Ref">Salonen JT et al. Association between cardiovascular death and myocardial
infarction and serum selenium in a matched-pair longitudinal study. <em>Lancet</em>
1982;ii:175.</li>

<li class="Ref">Shamberger RJ, Willis CE. Epidemiological studies on selenium and heart
disease. <em>Fed Proc</em> 1976;35:578 [abstract #2061].</li>

<li class="Ref">Korpela H, Kumpulainen J, Jussila E, et al. Effect of selenium supplementation
after acute myocardial infarction. <em>Res Comm Chem Pathol Pharmacol</em> 1989;
65:249&#8211;52.</li>

<li class="Ref">Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset
vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin
C therapy. <em>Circulation</em> 1999;99:1156&#8211;60.</li>

<li class="Ref">Frei B. Ascorbic acid protects lipids in human plasma and low-density
lipoprotein against oxidative damage. <em>Am J Clin Nutr</em> 1991;54:1113S&#8211;8S.</li>

<li class="Ref">Balz F. Antioxidant Vitamins and Heart Disease. Presented at the 60th Annual
Biology Colloquium, Oregon State University, February 25, 1999.</li>

<li class="Ref">Salonen JT, Nyyss&#246;nen K, Salonen R, et al. Antioxidant supplementation in
atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamin E and C
on 3-year progression of carotid atherosclerosis. <em>J Intern Med</em>
2000;248:177&#8211;86.</li>

<li class="Ref">Belcher JD, Balla J, Balla G, et al. Vitamin E, LDL, and endothelium: Brief
oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. <em>
Arterioscler Thromb</em> 1993;13:1779&#8211;89.</li>

<li class="Ref">Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of
vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). <em>
Lancet</em> 1996;347:781&#8211;6.</li>

<li class="Ref">Rimm E. Micronutrients, Coronary Heart disease and cancer: Should we all be on
supplements? Presented at the 60th Annual Biology Colloquium, Oregon State University,
February 25, 1999.</li>

<li class="Ref">Salonen JT, Nyyss&#246;nen K, Salonen R, et al. Antioxidant supplementation in
atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamin E and C
on 3-year progression of carotid atherosclerosis. <em>J Intern Med</em>
2000;248:177&#8211;86.</li>

<li class="Ref">Stampfer MJ, Malinow R, Willett WC, et al. A prospective study of plasma
homocyst(e)ine and risk of myocardial infarction in US physicians. <em>JAMA</em>
1992;268:877&#8211;81.</li>

<li class="Ref">Bostom AG, Silbershatz H, Rosenberg IH, et al. Nonfasting plasma total
homocysteine levels and all-cause and cardiobascular disease mortality in elderly Framingham
men and women. <em>Arch Intern Med</em> 1999;159:1077&#8211;80.</li>

<li class="Ref">Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart
disease incidence in relation to fasting total homocysteine, related genetic polymorphisms,
and B vitamins. <em>Circulation</em> 1998;98:204&#8211;10.</li>

<li class="Ref">Kuller LH, Evans RW. Homocysteine, vitamins, and cardiovascular disease. <em>
Circulation</em> 1998;98:196&#8211;9 [editorial/review].</li>

<li class="Ref">Stolzen berg-Solomon RZ, Miller ER III, Maguire MG, et al. Association of
dietary protein intake and coffee consumption with serum homocysteine concentrations in an
older population. <em>Am J Clin Nutr</em> 1999;69:467&#8211;75.</li>

<li class="Ref">Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary
determinants of homocysteinemia in an elderly population. <em>JAMA</em>
1993;270:2693&#8211;8.</li>

<li class="Ref">Ubbink JB, Hayward WJ, van der Merwe A, et al. Vitamin requirements for the
treatment of hyperhomocysteinemia in humans. <em>J Nutr</em> 1994;124:1927&#8211;33.</li>

<li class="Ref">Manson JB, Miller JW. The effects of vitamin B12, B6, and folate on blood
homocysteine levels. <em>Ann NY Acad Sci</em> 1992;669:197&#8211;204 [review].</li>

<li class="Ref">Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart
disease incidence in relation to fasting total homocysteine, related genetic polymorphisms,
and B vitamins. <em>Circulation</em> 1998;98:204&#8211;10.</li>

<li class="Ref">Hackam DG, Peterson JC, Spence JD. What level of plasma homocyst(e)ine should
be treated? <em>Am J Hypertens</em> 2000;13:105&#8211;10.</li>

<li class="Ref">Franken DG, Boers GHJ, Blom HJ, et al. Treatment of mild hyperhomocysteinemia
in vascular disease patients. <em>Arterioscler Thromb</em> 1994;14:465&#8211;70.</li>

<li class="Ref">Ubbink JB, Vermaak WJH, van der Merwe A, et al. Vitamin requirements for the
treatment of hyperhomocysteinemia in humans. <em>J Nutr</em> 1994;124:1927&#8211;33.</li>

<li class="Ref">Ubbink JB, van der Merwe A, Vermaak WJH, Delport R. Hyperhomocysteinemia and
the response to vitamin supplementation. <em>Clin Investig</em> 1993;71:993&#8211;8.</li>

<li class="Ref">Ronzio RA. Antioxidants, nutraceuticals and functional foods. <em>Townsend
Letter for Doctors and Patients</em> 1996;Oct:34&#8211;5 [review].</li>

<li class="Ref">Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary antioxidant flavonoids
and risk of coronary heart disease: the Zutphen Elderly Study. <em>Lancet</em>
1993;342:1007&#8211;11.</li>

<li class="Ref">Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk
of coronary heart disease and cancer in the Seven Countries Study. <em>Arch Intern Med</em>
1995;155:381&#8211;6.</li>

<li class="Ref">Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary
mortality in Finland: a cohort study. <em>BMJ</em> 1996;312:478&#8211;81.</li>

<li class="Ref">Rimm EB, Katan MB, Ascherio A, et al. Relation between intake of flavonoids
and risk for coronary heart disease in male health professionals. <em>Ann Intern Med
1996</em>; 125:384&#8211;9.</li>

<li class="Ref">Hertog MGL, Sweetnam PM, Fehily AM, et al. Antioxidant flavonols and ischemic
heart disease in a Welsh population of men: the Caerphilly Study. <em>Am J Clin Nutr</em>
1997;65:1489&#8211;94.</li>

<li class="Ref">Boberg M, Vessby B, Selinus I. Effects of dietary supplementation with n-6 and
n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in
hypertriglcyeridaemic patients. <em>Acta Med Scand</em> 1986;220:153&#8211;60.</li>

<li class="Ref">Horrobin DF, Manku MS. How do polyunsaturated fatty acids lower plasma
cholesterol levels? <em>Lipids</em> 1983;558&#8211;62.</li>

<li class="Ref">Morrison LM, Branwood AW, Ershoff BH, et al. The prevention of coronary
arteriosclerotic heart disease with chondroitin sulfate A: Preliminary report. <em>Exp Med
Surg</em> 1969;27:278&#8211;89.</li>

<li class="Ref">Morrison LM, Enrick NL. Coronary heart disease: Reduction of death rate by
chondroitin sulfate A. <em>Angiology</em> 1973;24:269&#8211;82.</li>

<li class="Ref">Bertelli AA, Giovanninni L, Bernini W, et al. Antiplatelet activity of
cis-resveratrol. <em>Drugs Exp Clin Res</em> 1996;22(2):61&#8211;3.</li>

<li class="Ref">Chen CK, Pace-Asciak. CR. Vasorelaxing activity of resveratrol and quercetin
in isolated rat aorta. <em>Gen Pharm</em> 1996;27(2):363&#8211;6.</li>

<li class="Ref">Pace-Asciak CR, Rounova O, Hahn SE, et al. Wines and grape juices as
modulators of platelet aggregation in healthy human subjects. <em>Clin Chim Acta</em>
1996;246(1&#8211;2):163&#8211;82.</li>

<li class="Ref">Salonen JT, Nyss&#246;nen K, Korpela H, et al. High stored iron levels are
associated with excess risk of myocardial infarction in Eastern Finnish
men.<em>Circulation</em> 1992;86:803&#8211;11.</li>

<li class="Ref">Van Asperen IA, Feskens EJM, Bowles CH, Kromhout D. Body iron stores and
mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men
and women. <em>Int J Epidemiol</em> 1995;24:665&#8211;70.</li>

<li class="Ref">Iribarren C, Sempos CT, Eckfeldt JH, Folsom AR. Lack of association between
ferritin level and measures of LDL oxidation: the ARIC study. <em>Atherosclerosis</em>
1998;139:189&#8211;95.</li>

<li class="Ref">Corti M-C, Guralnik JM, Salive ME, et al. Serum iron level, coronary artery
disease, and all-cause mortality in older men and women. <em>Am J Cardiol</em>
1997;79:120&#8211;7.</li>

<li class="Ref">Tzonou A, Lagiou P, Trichopoulou A, et al. Dietary iron and coronary heart
disease risk: a study from Greece. <em>Am J Epidemiol</em> 1998;147:161&#8211;6.</li>

<li class="Ref">Kiechl S, Willeit J, Egger G, et al. Body iron stores and the risk of carotid
atherosclerosis. <em>Circulation</em> 1997;96:3300&#8211;7.</li>

<li class="Ref">Danesh J, Appleby P. Coronary heart disease and iron status. Meta-analyses of
prospective studies. <em>Circulation</em> 1999;99:852&#8211;4.</li>

<li class="Ref">de Valk B, Marx MMJ. Iron, atherosclerosis, and ischemic heart disease. <em>
Arch Intern Med</em> 1999;159:1542&#8211;8 [review].</li>

<li class="Ref">Klipstein-Grobusch K, Launer LJ, Geleijnse JM, et al. Serum carotenoids and
atherosclerosis. The Rotterdam Study. <em>Atherosclerosis</em> 2000;148:49&#8211;56.</li>

<li class="Ref">Koscienlny J, Kl&#252;&#223;endorf D, Latza R, et al. The anti-atherosclerotic
effect of <em>Allium sativum. Atherosclerosis</em> 1999;144:237&#8211;49.</li>

<li class="Ref">Neil HAW, Silagy CA, Lancaster T, et al. Garlic powder in the treatment of
moderate hyperlipidaemia: A controlled trial and a meta-analysis. <em>J R Coll Phys</em>
1996;30:329&#8211;34.</li>

<li class="Ref">McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with
hypercholesterolemia. <em>Arch Pediatr Adolesc Med</em> 1998;152:1089&#8211;94.</li>

<li class="Ref">Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and
lipoproteins. <em>Arch Intern Med</em> 1998;158:1189&#8211;94.</li>

<li class="Ref">Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on
serum lipoproteins and cholesterol metabolism. <em>JAMA</em> 1998;279:1900&#8211;2.</li>

<li class="Ref">Lawson L. Garlic oil for hypercholesterolemia&#8211;negative results. <em>
Quart Rev Natural Med</em> 1998;Fall:185&#8211;6.</li>

<li class="Ref">Garlic powder for hyperlipidemia&#8211;analysis of recent negative results.
<em>Quart Rev Natural Med</em> 1998;Fall:187&#8211;9.</li>

<li class="Ref">Kiesewetter H, Jung F, Pindur G, et al. Effect of garlic on thrombocyte
aggregation, microcirculation and other risk factors. <em>Int J Pharm Ther Toxicol</em>
1991;29(4):151&#8211;5.</li>

<li class="Ref">Srivastava KC, Tyagi OD. Effect of a garlic derived principle (ajoene) on
aggregation and arachidonic acid metabolism in human blood platelets. <em>Prostagl Leukotr Ess
Fatty Acids</em> 1993;49:587&#8211;95.</li>

<li class="Ref">Munday JS, James KA, Fray LM, et al. Daily supplementation with aged garlic
extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation. <em>
Atherosclerosis</em> 1999;143:399&#8211;404.</li>

<li class="Ref">Braquet P, Touqui L, Shen TS, Vargaftig BB. Perspectives in platelet
activating factor research. <em>Pharmacol Rev</em> 1987;39:97&#8211;210.</li>

<li class="Ref">Brown DJ. <em>Herbal Prescriptions for Better Health.</em> Rocklin, CA: Prima
Publishing, 1996, 119&#8211;28.</li>

<li class="Ref">Kiesewetter H, Jung F, Mrowietz C, et al. Effects of garlic on blood fluidity
and fibrinolytic activity: A randomised, placebo-controlled, double-blind study. <em>Br J Clin
Pract Suppl</em> 1990;69:24&#8211;9.</li>

<li class="Ref">Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of <em>Ginkgo biloba</em>
on fluidity of blood and peripheral microcirculation in volunteers. <em>
Arzneimittelforschung</em> 1990;40:589&#8211;93.</li>

<li class="Ref">Brown D, Austin S. <em>Hyperlipidemia and Prevention of Coronary Heart
Disease.</em> Seattle: Natural Product Research Consultants, 1997, 4&#8211;6.</li>

<li class="Ref">Phelps S, Harris WS. Garlic supplementation and lipoprotein oxidation
susceptibility. <em>Lipids</em> 1993;28(5):475&#8211;7.</li>

<li class="Ref">Yan LJ, Droy-Lefaix MT, Packer L. <em>Ginkgo biloba</em> extract (EGb 761)
protects human low density lipoproteins against oxidative modification mediated by copper.
<em>Biochem Biophys Res Comm</em> 1995;212:360&#8211;6.</li>

<li class="Ref">Singh K, Chander R, Kapoor NK. Guggulsterone, a potent hypolipidaemic,
prevents oxidation of low density lipoprotein. <em>Phytother Res</em>
1997;11:291&#8211;4.</li>

<li class="Ref">Olson BH, Anderson SM, Becker MP, et al. Psyllium-enriched cereals lower blood
total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic
adults: Results of a meta-analysis. <em>J Nutr</em> 1997;127:1973&#8211;80.</li>

<li class="Ref">Sharma RD, Raghuram TC, Dayasagar Rao V. Hypolipidaemic effect of fenugreek
seeds. A clinical study. <em>Phytother Res</em> 1991;5:145&#8211;7.</li>

<li class="Ref">Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green tea
in man. <em>Eur J Clin Nutr</em> 1996;50:28&#8211;32.</li>

<li class="Ref">van het Hof KH, de Boer HS, Wiseman SA, et al. Consumption of green or black
tea does not increase resistance of low-density lipoprotein to oxidation in humans. <em>Am J
Clin Nutr</em> 1997;66:1125&#8211;32.</li>

<li class="Ref">Bordia A, Verma SK, Srivastava KC. Effect of ginger (<em>Zingiber
officinale</em> Rosc) and fenugreek (<em>Trigonella foenumgraceum</em> L) on blood lipids,
blood sugar, and platelet aggregation in patients with coronary artery disease. <em>
Prostagland Leukotrienes Essential Fatty Acids</em> 1997;56:379&#8211;84.</li>

<li class="Ref">Lumb AB. Effect of dried ginger on human platelet function. <em>Thromb
Haemost</em> 1994;7:110&#8211;1.</li>

<li class="Ref">Janssen PL, Meyboom S, van Staveren WA, et al. Consumption of ginger
(<em>Zingiber officinale</em> Roscoe) does not affect ex vivo platelet thromboxane production
in humans. <em>Eur J Clin Nutr</em> 1996;50:772&#8211;4.</li>

<li class="Ref">Srivastava R, Dikshit M, Srimal RC, Dhawan BN. Anti-thrombotic action of
curcumin<em>. Throm Res</em> 1985;404:413&#8211;7.</li>

<li class="Ref">Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice
turmeric (<em>Curcuma longa</em>) inhibits aggregation and alters eicosanoid metabolism in
human blood platelets. <em>Prost Leuk Essen Fat Acids.</em> 1995;52:223&#8211;7.</li>

<li class="Ref">Pulliero G, Montin S, et al. Ex vivo study of the inhibitory effects of <em>
Vaccinium myrtillus</em> (bilberry) anthocyanosides on human platelet aggregation. <em>
Fitoterapia</em> 1989;60:69&#8211;75.</li>

<li class="Ref">Liu J. Effect of <em>Paeonia obovata</em> 801 on metabolism of thromboxane B2
and arachidonic acid and on platelet aggregation in patients with coronary heart disease and
cerebral thrombosis. <em>Chin Med J</em> 1983;63:477&#8211;81 [in Chinese].</li>

<li class="Ref">Felix W, Schmidt Y, Nieberle J. Protective effect of <em>Ruscus</em> extract
against injury of vascular endothelium and vascular smooth muscle caused by ethracrynic acid.
<em>Int Angiol</em> 1983;3:77.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Atherosclerosis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:16 GMT -->
</html>

